A robotic assisted surgery for bladder lesion excision.
Who can participate
Age range
22 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. The subject is 22 years or older.
. The subject is eligible and fit for transurethral bladder lesion removal and/or biopsy and has an appropriate indication to go through this surgery.
. The subject is willing and able to provide written informed consent and comply with the study protocol.
. The subject can undergo general anesthesia per anesthesiologist assessment.
. The subject's planned aggregated bladder lesion(s) excision specimens are smaller than 3 cm.
Exclusion criteria
. The subject has acute untreated urinary tract infection or urosepsis.
. The subject has a documented nickel allergy or nickel sensitivity.
. The subject is confirmed to be or suspected to be pregnant.
. The subject is receiving anticoagulants and is unable or not willing to cease the medication for the investigational procedure.
. The subject belongs to a vulnerable group (prisoner, etc.)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Detrusor muscle presence in the pathologic specimen after VES procedure
Timeframe: Through study completion, an average of 30 days
2
Adverse events
Timeframe: Intraoperative
3
Adverse events
Timeframe: Through study completion, an average of 30 days